Summary: By Mya Blake The FDA has asked for more clinical data pertaining to a pending new birth control drug called Lybrel It is being reported, that the USFDA has put a temporary freeze on the release of a pill designed to stop women from menstrating. The drug has already been given a lengthy hold due to the
Image Dimensions: 200 x 134
Image originally found here.